Syenza Foundation

Syenza Foundation

The Value Science Foundation

Syenza Foundation is devoted to strengthening value based healthcare systems. We nurture independent thinking, market access research, and building social capital. We work with stakeholders across all segments of society to accelerate the diffusion of current and new healthcare technologies.

What we do

Three ways we strengthen value-based healthcare.

Pricing Consulting

Value-based Health Care depends on a rigorous approach to evaluating the price of innovations. Full pricing it out, shared-value is in. Syenza's Pricing services include budget impact analysis, pricing strategy, and outcomes based pricing.

Independent Thinking →

Pharma Market Access Consulting

Pharma Market Access requires a new approach to Value-based Health Care. Old tools and methods no longer apply. Syenza's Pharma Market Access services include market access strategy, market access skills development, and value communications strategies.

Market Access Research →

Healthcare Consulting

Value-based Health Care changes how we look at healthcare systems. It's no longer business as usual. Syenza's Healthcare Consulting services include health policy analysis, health technology assessment systems, and evidence of value studies.

Building Social Capital →

Our story

The Syenza Story

Syenza Foundation builds on our heritage at Syenza. Along the way we’ve learnt that accelerating value-based healthcare systems will require facilitating the exchange of knowledge and information. We’ve come a long way.

Travelled 4,928,768 km implementing Access Projects
Written 1,252 p. presenting our Analytic Work
Delivered 320 h of Market Access Workshops
Exchanged Views in 21,384 min of Global Conferencing
  • January 2008Syenza starts consulting at WHO and Harvard Medical School
  • March 2011Syenza accepts outsourced projects from prominent consulting firms
  • June 2015Syenza strengthens its market access and pharmacoeconomics services for pain management and rare diseases.
  • September 2016Syenza introduces its Client Chart and start working direct with top Clients
  • June 2017Syenza's therapeutic area pharmacoeconomic projects cover cancer, CVD, rheumatoid arthritis, epilepsy, multiple sclerosis, HIV/AIDS.
  • April 2018Syenza introduces the first fully online applied pharmacoeconomics course.
  • September 2019A lot of miles implementing access projects, and delivered much analytics.

How we Work with Stakeholders

We are devoted to accelerating value-based healthcare systems. To this end, we commit to upholding essential principles in all of our dealings with stakeholders. They include: Consistency, Flexibility, Responsiveness, and Transparency.

ConsistencyFlexibilityResponsivenessTransparency

In their words

What the people we work with value most.

Self initiative to take the best path and overcome issues without seeking directions from us every time — saves everyone a lot of time and helps with timelines.
Regional Market Access Manager Boehringer Ingelheim
Insight into proposed projects, and management of timelines and deliverables. Having articles on outcomes of the project once the project is completed.
Country Manager Genzyme
The collaborative efforts in defining the project, the discussions on the insights generated and follow-up and the further assistance that was offered in understanding the landscape.
Senior Market Access Manager Amgen
Expertise in the field, communication and constant project status reporting.
Global Market Access Executive Novo Nordisk
Dedicated and knowledgeable with a high interest in delivering value-adding outcomes.
Global Public Affairs Director Novo Nordisk
Good insight into the market and new perspectives of looking at access.
Head of Market Access Merck
The regular feedback and the commitment to timelines and delivery.
Market Access Manager Sanofi

Our team

The people behind the Foundation.

João
João
René
René
Teresa
Teresa